基于非核苷类逆转录酶抑制剂方案序贯中断后的治疗耐药性。 - Suppr | 超能文献

Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen.

作者信息

Dargere Sylvie, Parienti Jean-Jacques, Verdon Renaud

出版信息

AIDS. 2007 Apr 23;21(7):879-80. doi: 10.1097/QAD.0b013e3280b077b6.

DOI:10.1097/QAD.0b013e3280b077b6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen.

AIDS. 2007 Apr 23;21(7):879-80. doi: 10.1097/QAD.0b013e3280b077b6.

2

HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.

Int J STD AIDS. 2007 Dec;18(12):832-4. doi: 10.1258/095646207782716992.

3

HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.

4

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.

AIDS. 2009 Jul 31;23(12):1605-8. doi: 10.1097/QAD.0b013e32832d9031.

5

HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.

Antivir Ther. 2008;13(4):537-45.

6

Effectiveness and durability of non-nucleoside reverse transcriptase inhibitor-based therapy in HIV clinical practice.

AIDS. 2007 Apr 23;21(7):880-2. doi: 10.1097/QAD.0b013e3280b079a6.

7

HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.

AIDS Rev. 2009 Jul-Sep;11(3):165-73.

8

Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.

Arch Virol. 2007;152(10):1799-805. doi: 10.1007/s00705-007-1019-9. Epub 2007 Jul 6.

9

Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy.

Antivir Ther. 2009;14(5):713-22.

10

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.

Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4.

引用本文的文献

1

Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".

JAMA Intern Med. 2013 Feb 25;173(4):306-7. doi: 10.1001/jamainternmed.2013.2858.

2

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.

AIDS. 2008 Nov 12;22(17):2279-89. doi: 10.1097/QAD.0b013e328311d16f.